MLICM
SABR icon

Metropolitan Life Insurance Company (MetLife)’s Sabre SABR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SABR Stock Details SABR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,584
Closed -$35.3K – 1720
2024
Q1 		$35.3K Sell
14,584
-2,702
-16% -$9.07K ﹤0.01% 1578
2023
Q4 		$76.1K Sell
17,286
-1,602
-8% -$6.18K ﹤0.01% 1226
2023
Q3 		$84.8K Buy
18,888
+1,271
+7% +$5.77K ﹤0.01% 1099
2023
Q2 		$56.2K Buy
+17,617
New +$63.7K ﹤0.01% 1357
2023
Q1 		– Sell
-20,165
Closed -$125K – 2441
2022
Q4 		$125K Buy
20,165
+2,149
+12% +$12K 0.01% 939
2022
Q3 		$92.8K Sell
18,016
-1,673
-8% -$11.2K ﹤0.01% 1059
2022
Q2 		$115K Buy
+19,689
New +$164K 0.01% 975
2022
Q1 		– Sell
-72,795
Closed -$625K – 2613
2021
Q4 		$625K Sell
72,795
-976
-1% -$9.36K 0.01% 1277
2021
Q3 		$873K Buy
+73,771
New +$836K 0.01% 1067
2021
Q2 		– Sell
-60,017
Closed -$889K – 2850
2021
Q1 		$889K Buy
60,017
+3,118
+5% +$42.3K 0.01% 1036
2020
Q4 		$684K Buy
56,899
+247
+0.4% +$2.28K 0.01% 1163
2020
Q3 		$369K Buy
56,652
+3,229
+6% +$23.9K 0.01% 1415
2020
Q2 		$431K Sell
53,423
-21,781
-29% -$154K 0.01% 1319
2020
Q1 		$446K Sell
75,204
-4,028
-5% -$67.4K 0.01% 1112
2019
Q4 		$1.78M Buy
79,232
+451
+0.6% +$10K 0.03% 601
2019
Q3 		$1.76M Sell
78,781
-10,784
-12% -$254K 0.03% 561
2019
Q2 		$1.99M Sell
89,565
-540
-0.6% -$11.6K 0.03% 525
2019
Q1 		$1.93M Sell
90,105
-370
-0.4% -$8.21K 0.03% 513
2018
Q4 		$1.96M Buy
90,475
+8,107
+10% +$196K 0.04% 435
2018
Q3 		$2.15M Buy
+82,368
New +$2.11M 0.04% 480
2015
Q4 		– Sell
-8,290
Closed -$225K – 2624
2015
Q3 		$225K Hold
8,290
– – ﹤0.01% 2207
2015
Q2 		$197K Buy
+8,290
New +$209K ﹤0.01% 2411
2015
Q1 		– Sell
-3,185
Closed -$65K – 2404
2014
Q4 		$65K Buy
3,185
+85
+3% +$1.54K ﹤0.01% 2615
2014
Q3 		$56K Sell
3,100
-23
-0.7% -$433 ﹤0.01% 2627
2014
Q2 		$63K Buy
+3,123
New +$55.6K ﹤0.01% 2726

Other funds holding SABR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
DG
Discerene Group Stamford, Connecticut $946M AUM 1.38% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SABR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sabre (SABR) in Q2 2024, closing a stake of 14,584 shares — an estimated $35.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SABR in Q2 2014 and held it in 25 quarters. The position peaked at $2.15M in Q3 2018. 241 funds tracked by Wall St. Rank hold SABR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Sabre position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14,584 Sabre shares in Q2 2024, an estimated $35.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Sabre in Q2 2014 and held it in 25 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Sabre position peaked at $2.15M in Q3 2018.
  • 241 funds tracked by Wall St. Rank held Sabre as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.